4.990
4.99 (0%)
As of Dec 20, 2024
Corvus Pharmaceuticals, Inc. [CRVS]
Source:
Company Overview
Corvus Pharmaceuticals, Inc is a clinical stage biopharmaceutical company. Our strategy is to focus our efforts on the development of immune modulator product candidates with the potential to treat solid cancers, T cell lymphomas, autoimmune, allergic and infectious diseases.
Country | United States |
Headquarters | burlingame , california |
Phone Number | ( 650 ) 900-4520 |
Industry | manufacturing |
CEO | Richard A. Miller, M.D. |
Website | www.corvuspharma.com |